Benefits persist in T cell therapy for children with relapsed leukemia
Monday, December 8, 2014 - 16:01
in Health & Medicine
An innovative therapy against a highly aggressive leukemia continues to show highly promising results in children treated in a pilot study. Of 39 children receiving bioengineered T cells, 92 percent had no evidence of cancer a month after treatment.